NorthWest Biotherapeutics Inc (NWBO)

[Truthfan]

“I don't see LP's name nowhere in this new Company neither in the Management nor in the Directors. Did I miss it? If true then it is clear that LP is focusing only in NWBO and DcVax. For me with my present knowledge in this area, it is a very good sign.”

Just mentioning as interesting to this MB……See Inmune’s SEC filing on connections:

J. Kelly Ganjei, CEO, Cognate Bioservices - Director

Toucan Capital Fund III (listed under Beneficial Owners of more than 5%


“INKmune Manufacturing
 
We intend to contract with third parties for the manufacture of our compounds for investigational purposes, for preclinical and clinical testing and for any FDA approved products for commercial sale. Pre-clinical and clinical material for the early clinical trials with INKmune has been manufactured under the direction of Mark Lowdell and Advent Bioservices International, our strategic partner, at a licensed GMP facility. The master cell bank, working cell bank and individual product doses were completed in July 2018. This clinical material is planned for use in the Phase I/II clinical trials in ovarian cancer. If we raise adequate capital to initiate the high-risk MDS Phase I/II trials, additional working cell banks and therapeutic product will be produced from the existing master cell bank. This process takes approximately 6 months and is not anticipated to delay the initiation of the high-risk MDS Phase I/II trials. We may transfer the manufacturing to a different commercial contract manufacturing organization after completion of these Phase II studies.”

https://www.sec.gov/Archives/edgar/data/1711754/000164033418001703/inmune_s1.htm